Sarepta Therapeutics (SRPT) last issued guidance on August 2, 2022 for fiscal year 2022. The company guided revenue in the range of $905.00M - $920.00M for the period.
Review all historical guidance issued by Sarepta Therapeutics, including EPS and revenue forecasts across quarterly and annual periods.
The most recent guidance for Sarepta Therapeutics (SRPT) was reported on August 2, 2022 for the fiscal year 2022. Sarepta Therapeutics forecasted revenue between $905.00M and $920.00M for the period.
Sarepta Therapeutics (SRPT) guided revenue in the range of $905.00M to $920.00M for the fiscal year 2022.
Sarepta Therapeutics (SRPT) last issued guidance on August 2, 2022 for the fiscal year 2022.